NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Genprex, Inc. Common Stock Share Price Chart

O H L

Genprex, Inc. Common Stock Performance Overview

Days Range
$3.37Low
$3.37High

Markets Today

Previous Close$3.46
Open$3.37
Volume13,047
Day's Range$3.37 - $3.37
52W Range$3.26 - $1,210.00
Market Cap$2.80 M

Historical Performance

1M Returns-12.41
3M Returns-73.43
6M Returns-92.18
1Y Returns-98.71
5Y Returns-100.00
10Y ReturnsNA

Genprex, Inc. Common Stock Fundamentals

Market Cap$2.80 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-3.39
EPS TTM$-172.97
Quarterly Earnings Growth YOYN/A
PB Ratio0.12
EBITDA$-15.52 M
Profit MarginN/A
Market Cap$2.80 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-3.39
EPS TTM$-172.97
Quarterly Earnings Growth YOYN/A
PB Ratio0.12
EBITDA$-15.52 M
Profit MarginN/A

Genprex, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$3.97 M-$4.68 M-$3.35 M-$3.52 M-$4.49 M-$4.48 M
EBITDA -$3.97 M-$4.68 M-$3.35 M-$3.52 M-$4.49 M-$4.48 M
Interest Expense $0$0$0$0$0$0
Depreciation $0$0$0$0$0$0
Income Before Tax -$3.96 M-$4.67 M-$3.80 M-$3.79 M-$4.46 M-$4.45 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.96 M-$4.67 M-$3.80 M-$3.79 M-$4.46 M-$4.45 M
Net Profit Margin ------

Genprex, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $24.16 K$33.15 K$1.00 K$150$9.04 K$506
Reserve & Surplus -$158.76 M-$163.44 M-$167.24 M-$171.03 M-$175.49 M-$179.94 M
Non-Current Liabilities $0$0$243.00 K$22.50 K$22.50 K$0
Current Liabilities $2.14 M$2.44 M$2.55 M$2.17 M$3.35 M$2.34 M
Total Liabilities $2.14 M$2.44 M$2.79 M$2.20 M$3.38 M$2.34 M
Fixed Assets $1.85 M$1.77 M$1.85 M$1.80 M$1.50 M$1.29 M
Current Assets $4.16 M$2.06 M$1.72 M$8.36 M$18.80 M$15.84 M
Total Assets $6.01 M$3.83 M$3.56 M$10.16 M$20.31 M$17.14 M

Genprex, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.96 M-$4.67 M-$3.80 M-$3.79 M-$4.46 M-$4.45 M
Operating Cash Flow -$4.16 M-$3.86 M-$3.19 M-$4.10 M-$3.14 M-$5.14 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $6.03 M$1.74 M$2.94 M$10.83 M$13.36 M$2.24 M
Change in Cash $1.87 M-$2.12 M-$243.53 K$6.73 M$10.22 M-$2.90 M

Genprex, Inc. Common Stock Return Calculator

The Genprex, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$0
Invested Amount$10,000
Est. Returns$-10,000
Invest in USA Stock Today

About Genprex, Inc. Common Stock

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

FAQs

Genprex, Inc. Common Stock (GNPX) share price as of September 18, 2026 is $3.37. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Genprex, Inc. Common Stock (GNPX) Share by opening an international trading account with Angel One.
Purchasing Genprex, Inc. Common Stock (GNPX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Genprex, Inc. Common Stock (GNPX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Genprex, Inc. Common Stock (GNPX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Genprex, Inc. Common Stock on September 18, 2026, is $2.80 M.
Genprex, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Genprex, Inc. Common Stock (GNPX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91